Navigation Links
'Smart' genetic therapy helps the body to heal itself

of the gene that code for the disease), the processing of the genetic code for dystrophin ?a protein important for the muscle fibre membrane - can be manipulated in such a manner that certain units ('exons') are skipped. In this way, the readability of the code can be restored and the progress of DMD delayed or even stopped.

In collaboration with the Dutch biotech company Prosensa BV, and supported by the national and international Duchenne Parent Projects, and governmental and charity funds, Dr. J. van Deutekom and her team will soon start a clinical trial, based on intramuscular injection of a single dose of an anti-sense drug that induces the skipping of exon 51 from the DMD gene. Six Dutch DMD patients aged between 8 and 16 years with genetic mutations that are correctable by skipping that particular exon will take part.

This human trial is being supported by animal work. The team has used the muscular dystrophy mouse model to study optimal dose regimes, and further study exon skipping levels. This study found no clinical adverse signs, and the restoration of dystrophin levels, even in the heart.

"Of all the different strategies against DMD currently being contemplated," said Professor van Ommen, "this is the one closest to clinical application. The patients in the trial have already been pre-screened, and we have seen the effect of the anti-sense drug in their isolated and cultured muscle cells. We are optimistic that this small scale trial will be the precursor of major clinical studies, which will lead in turn to a safe and efficient full body treatment for DMD patients. Currently no therapy is available for this disease, which represents a huge psychosocial and economic burden to patients, carers and society."


'"/>

Source:European Society of Human Genetics


Page: 1 2 3 4

Related biology news :

1. Smart nanoprobes light up disease
2. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Mouse brain tumors mimic those in human genetic disorder
5. Scientists identify genetic pathways essential to RNA interference
6. Researchers trace evolution to relatively simple genetic changes
7. Key mechanism in genetic inheritance during cell division identified
8. Scientists identify genetic pathways essential to RNA interference
9. MUHC scientists describe genetic resistance to rampant virus
10. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
11. Montreal researchers probe the genetic basis of memory
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Smart genetic therapy helps the body heal itself

(Date:5/24/2013)... immune system to combat metastatic cancer , Cancer ... by the immune system. Stimulation of the immune system ... many factors that cause the immune system to ignore ... function to suppress the immune system response. In this ... researchers led by Ronald Levy at Stanford University found ...
(Date:5/24/2013)... against Alzheimer,s disease, scientists have focused among other factors ... After all, it is the accumulation of A-beta that causes ... point for the formation of A-beta is APP. Alessia Soldano ... the function of APPL the fruit-fly version of APP ... Alessia Soldano (VIB/KU Leuven): "We have discovered that APPL ensures ...
(Date:5/23/2013)... Pacific Northwest National Laboratory honored more than ... of intellectual property at PNNL,s annual Intellectual Property ... The Department of Energy national laboratory named materials ... his work developing battery materials that can store ... electrical grid, and reduce the time it takes ...
Breaking Biology News(10 mins):JCI early table of contents for May 24, 2013 2JCI early table of contents for May 24, 2013 3JCI early table of contents for May 24, 2013 4JCI early table of contents for May 24, 2013 5JCI early table of contents for May 24, 2013 6JCI early table of contents for May 24, 2013 7JCI early table of contents for May 24, 2013 8A new strategy required in the search for Alzheimer's drugs? 2PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
... What would be your response to a radiological incident? How ... take care of us? How do we even know if we ... addressed at the 42nd Midyear Topical Meeting of the Health Physics ... San Antonio, Texas at the Henry B. Gonzales Convention Center. The ...
... that certain marginalized groups including the mentally ill, ... and Latinos fare worse than others in the ... fatalities. Now, a new study ... also experience greater terrorism-related fears and make more behavioral ...
... Newark, Delaware became the first electric utility in the ... power for the local electric grid. The ... to store energy and improve grid reliability. University of ... With the City of Newark,s approval, the UD team ...
Cached Biology News:42nd Mid-year Topical Meeting of the Health Physics Society 2Disabled and other vulnerable groups more susceptible to terrorism fears 2City of Newark first in nation using cars to power grid 2
(Date:5/23/2013)... May 23, 2013 PuraMed BioScience ® ... marketer of over-the-counter (OTC) medicinal and healthcare products, ... on the company based on low market capitalization ... Non-Prescription, All Natural Product to Treat Migraine Headaches ... #1 Prescription Competitor , Currently Available Nationwide ...
(Date:5/23/2013)... 23, 2013 VG Energy, an agricultural ... DAK Renewable Research to conduct field trials using ... Energy is a majority owned subsidiary of VG ... VG Energy,s exclusively licensed compound LipidMax selectively inhibits ... in plants, possessing a wide variety of applications ...
(Date:5/23/2013)... 2013 On April 19th the ... to search for the growing antibiotic resistant bacteria that ... a year long study were released late last month ... meats, over previous years. For those suffering from bacteria ... antibiotic resistant bacteria in food, may eventually help breed ...
(Date:5/23/2013)... May 23, 2013 Pressure BioSciences, Inc. (OTCQB: ... Company will host a teleconference to discuss its First ... update. The teleconference information is provided below: ... Daylight Time (EDT) Dial-in: (800) 875-3456 (U.S.); ... (Int,l) Passcode: VS22823 For those unable to ...
Breaking Biology Technology:PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2
... 28 Stryker Corporation (NYSE: SYK ) learned today ... has returned an indictment charging Stryker Biotech LLC and certain ... conspiracy to defraud the U.S. Food and Drug Administration (FDA), ... FDA. The Company disclosed in March of this year that ...
... The Center for Business Intelligence (CBI), a division of Advanstar ... panel on Regulatory Risks, Compliance and Validation at ... coming up November 2 - 3, 2009 at the Doubletree ... CDRH Division of Bioresearch Monitoring of the FDA , ...
... MINNEAPOLIS, Oct. 28 Techne Corporation,s (Nasdaq: TECH ... 30, 2009 decreased 6.4% to $26.8 million or $.72 ... per diluted share for the quarter ended September 30, ... due to foreign currency fluctuations, decreased consolidated net sales ...
Cached Biology Technology:Stryker Statement in Response to the Indictment of Its Biotech Division 2CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 2CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 3Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 2Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 3Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 4Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 5Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 6
WNV Core Antibody...
HSD17B3 Immunogen: HSD17B3 (NP_000188, 29 a.a. ~ 120 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rad51, N-terminal...
Phospho-mu-Opioid Receptor (Ser375) Antibody...
Biology Products: